Overview

Pediatric Schizophrenia Efficacy and Safety Study

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Efficacy and Safety study of Lurasidone in pediatric patients.
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion
Treatments:
Lurasidone Hydrochloride